Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mFOLFOX6”

152 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 152 results

Large-scale testing (Phase 3)Looking for participantsNCT06791512
What this trial is testing

MFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC

Who this might be right for
Colorectal Cancer (CRC)pMMR/MSS Adenocarcinoma of the Colon or Rectum
Jun Huang 166
Testing effectiveness (Phase 2)Study completedNCT01399684
What this trial is testing

A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Genentech, Inc. 127
Testing effectiveness (Phase 2)Ended earlyNCT03547999
What this trial is testing

A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC

Who this might be right for
Metastatic Colorectal Cancer
Patrick Boland 17
Testing effectiveness (Phase 2)Study completedNCT03618758
What this trial is testing

Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6

Who this might be right for
Gastric Cancer Stage IVPeritoneal CarcinomatosisIntraperitoneal Paclitaxel+1 more
Seoul National University Bundang Hospital 35
Early research (Phase 1)Study completedNCT03343301
What this trial is testing

Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

Who this might be right for
Gastrointestinal CancerGastrointestinal Cancer MetastaticGastric Cancer
Five Prime Therapeutics, Inc. 12
Not applicableStudy completedNCT00729677
What this trial is testing

Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving Oxaliplatin

Who this might be right for
Colorectal CancerNauseaVomiting
Beth Israel Medical Center 64
Very early researchLooking for participantsNCT07328087
What this trial is testing

COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer Stage IIIColorectal Cancer Stage IV
Biogenea Pharmaceuticals Ltd. 12
Large-scale testing (Phase 3)Temporarily pausedNCT00316745
What this trial is testing

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07176182
What this trial is testing

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

Who this might be right for
Rectal Cancer PatientsRectal Cancer Stage IIRectal Cancer Stage III
Sixth Affiliated Hospital, Sun Yat-sen University 236
Testing effectiveness (Phase 2)Study completedNCT01161316
What this trial is testing

Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 194
Large-scale testing (Phase 3)Study completedNCT02967289
What this trial is testing

IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting

Who this might be right for
Colon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2)
UNICANCER 792
Large-scale testing (Phase 3)Study completedNCT01662869
What this trial is testing

Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 564
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05239650
What this trial is testing

Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC

Who this might be right for
CRC
Shanghai Henlius Biotech 50
Large-scale testing (Phase 3)Study completedNCT03231722
What this trial is testing

First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 435
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890624
What this trial is testing

MFOLFOXIRI Plus PD-1 Inhibitor Vs MFOLFOX6 As Neoadjuvant Therapy for Locally Advanced Colon Cancer

Who this might be right for
Colon Cancer (stage II & III)
Sun Yat-sen University 138
Testing effectiveness (Phase 2)Study completedNCT01374425
What this trial is testing

Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colorectal Cancer
Genentech, Inc. 376
Large-scale testing (Phase 3)UnknownNCT04338191
What this trial is testing

MFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 638
Large-scale testing (Phase 3)UnknownNCT03426371
What this trial is testing

Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial

Who this might be right for
Metastatic Colorectal Cancer
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. 570
Large-scale testing (Phase 3)Ended earlyNCT03654729
What this trial is testing

Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)

Who this might be right for
Colorectal CancerChemotherapy-induced Peripheral Neuropathy
Egetis Therapeutics 291
Large-scale testing (Phase 3)UnknownNCT04781270
What this trial is testing

MFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases

Who this might be right for
Colorectal CarcinomaLiver Metastases
Fudan University 308
Load More Results